Summary: OVERPRICED
Score: 9/20
MOS: -861%
Share Price: $98
Sticker Price: $10
Is Abbott Laboratories a good buy?
Speaking of pharma stocks, one of the biggest players in the market is Abbott Laboratories.
Founded in 1888 in the Chicago area, they now have grown to over 100,000 employees. Abbott is much more diversified than Incyte. They generate revenue from medical devices, nutritionals, diagnostics, and pharmaceuticals. Medical devices is the largest segment, and accounts for more than one-third of the company’s total revenues and profits. The medical devices business includes minimally invasive medical devices for heart diseases, stroke, carotid artery disease, and other vascular conditions.
Overall, Abbott is doing some really great work around medical device innovation but that doesn’t exactly make the stock a wise investment. That sticker price of $10 is a sure sign to look for better deals in the market.
—
The Summary, Score, and MOS of this stock may have changed since the posting of this review. Please login to Tykr to see up-to-date information.